Medicare Enrolled

Dr. Madhumati Kalavar, MD

Hematology · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
566 SCHENECTADY AVE, Brooklyn, NY 11203
7184838360
Registered in NPPES since 2006
NPI: 1215991070 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kalavar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalavar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kalavar

Dr. Madhumati Kalavar is a hematology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kalavar performed 706 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kalavar received a total of $12,274 from 53 pharmaceutical and/or device companies across 430 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kalavar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 28% volume in NY $12,274 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
706
Medicare services
Top 28% in NY for hematology
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
231 $73 $182
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
122 $81 $145
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
118 $13 $40
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
94 $121 $316
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
92 $102 $229
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
49 $8 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,274
Total received (2018-2024)
Avg $1,753/year across 7 years
Top 31% in NY for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
430
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,000
2023
$1,705
2022
$3,108
2021
$1,371
2020
$1,204
2019
$1,235
2018
$1,652

Payments by company (2024)

Janssen Biotech, Inc.
$305
E.R. Squibb & Sons, L.L.C.
$208
PFIZER INC.
$193
AstraZeneca Pharmaceuticals LP
$173
Merck Sharp & Dohme LLC
$159
Daiichi Sankyo Inc.
$139
Alexion Pharmaceuticals, Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$125
Stemline Therapeutics Inc.
$88
TAIHO ONCOLOGY, INC.
$77
Celgene Corporation
$69
Incyte Corporation
$60
Bayer Healthcare Pharmaceuticals Inc.
$60
Octapharma USA, Inc.
$33
PUMA BIOTECHNOLOGY, INC.
$31
GENZYME CORPORATION
$31
Amgen Inc.
$22
SpringWorks Therapeutics, Inc.
$20
Mirati Therapeutics, Inc.
$18
Lilly USA, LLC
$18
Eisai Inc.
$16
Sumitomo Pharma America, Inc.
$16
Astellas Pharma US Inc
$15
Top 3 companies account for 35.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,750
Janssen Biotech, Inc.
$1,131
E.R. Squibb & Sons, L.L.C.
$1,009
Amgen Inc.
$849
Takeda Pharmaceuticals U.S.A., Inc.
$724
Incyte Corporation
$555
PFIZER INC.
$539
GENZYME CORPORATION
$459
Lilly USA, LLC
$446
AstraZeneca Pharmaceuticals LP
$358
Merck Sharp & Dohme LLC
$343
Merck Sharp & Dohme Corporation
$339
Astellas Pharma US Inc
$332
TESARO, Inc.
$325
Novartis Pharmaceuticals Corporation
$295
Daiichi Sankyo Inc.
$261
Celgene Corporation
$205
Global Blood Therapeutics, Inc.
$189
Alexion Pharmaceuticals, Inc.
$188
Taiho Oncology, Inc.
$125
Eisai Inc.
$116
TAIHO ONCOLOGY, INC.
$114
Bayer Healthcare Pharmaceuticals Inc.
$108
Puma Biotechnology, Inc.
$106
Lexicon Pharmaceuticals, Inc.
$99
EMD Serono, Inc.
$97
Ipsen Biopharmaceuticals, Inc
$95
Gilead Sciences, Inc.
$94
Stemline Therapeutics Inc.
$88
Octapharma USA, Inc.
$86
Genentech USA, Inc.
$83
Janssen Scientific Affairs, LLC
$78
Sumitomo Pharma America, Inc.
$67
Dova Pharmaceuticals
$66
Mirati Therapeutics, Inc.
$60
Myovant Sciences Inc.
$52
ARRAY BIOPHARMA INC
$43
Seagen Inc.
$39
Secura Bio, Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$37
SOBI, INC
$31
PUMA BIOTECHNOLOGY, INC.
$31
Janssen Pharmaceuticals, Inc
$27
Clovis Oncology, Inc.
$25
EISAI INC.
$24
Pharmacyclics LLC, An AbbVie Company
$24
Exelixis Inc.
$21
Jazz Pharmaceuticals Inc.
$20
SpringWorks Therapeutics, Inc.
$20
AbbVie Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
INSYS Therapeutics Inc
$16
Sobi, Inc
$13
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · Alecensa · BLENREP · BOSULIF · BRAFTOVI · CALQUENCE · CAMZYOS · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ERLEADA · Enhertu · Erleada · FARYDAK · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PROMACTA · Pomalyst · REBLOZYL · RYDAPT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · TEPMETKO · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xermelo · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Brooklyn?
Compare hematologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
119
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
KINGS COUNTY HOSPITAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kalavar is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NY), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kalavar experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kalavar performed 231 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kalavar receive payments from pharmaceutical companies?
Yes. Dr. Kalavar received a total of $12,274 from 53 companies across 430 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalavar's costs compare to other hematologists in Brooklyn?
Dr. Kalavar's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalavar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →